Attributions Contents

For a detailed chronology of events, see our Phorm Timeline.
 

• Phorm 2008: Company information and controversial background including links to F-Secure, Symantec and CA.
   
• Phorm 2009: Korean market trial, grant of share options to non-exec directors, financial pressures and share placing, rejection by UK ISPs, disappearence of references to Korean trial.
   
• UK ISPs: Sources for UK ISP involvement with Phorm, focussing particularly on BT.
   
• Korean ISPs: Sources for Korean ISP involvement with Phorm, focussing particularly on Korea Telecom.
   
• ISP PII Leaks: Examples of the difficulties ISPs have of keeping personal information private.
   
• BT's 2006 and 2007 Trials: Articles, broadcasts, leaked documents, responses to Freedom of Information requests.
   
• BT's 2008 Trial: Log of events surrounding BT's third (and first public) trial of Phorm in Autumn 2008.
   
• How it Works: Richard Clayton's analysis, schematics (including BT's), further information on deep packet inspection.
   
• User Consent: Proposed interstitial page plus information on the anti-phishing features of free versions of browsers used by more than 90% of people.
   
• Websites blocking Phorm: How Amazon, WIkipedia, Livejournal and others have protected their intellectual property and that of their users from commercial exploitation by third parties. Also, what the BBC thinks.
   
• Consumer Surveys: In February 2009 two surveys were published which suggested there would be low consumer acceptance of Phorm and similar schemes.
   
• Public Debate 2008: Phorm public meeting, broadcasts and podcasts, parliamentary questions.
   
• Public Debate 2009: House of Lords Round Table, Facebook Campaign and more.
   
• Legal: Legal opinion from the Foundation for Information Policy Research plus further information on the Regulation of Investigatory Powers Act including Home Office Guidance and examples of two cases against civillians.
   
• BCS: Commentary from the British Computer Society including its chief executive's views on the ethics of working on Phorm-like products.
   
• UK ICO: The UK information Commissioner's announcement that Phorm mut be "opt-in" plus their response to a user whose web activity was tapped during BT's 2007 trial of Phorm.
   
• EU Response: Letter from the EU Commissioner to the UK Government asking questions about Phorm, and followup to this leading to the EU initiating infringement proceedings against the UK Government in April 2009.
   
• US Response: How Phorm-like schemes were discouraged by Congress and have now all been shelved.